Form 4 for TECH Bio-Techne
Accepted 2023-06-09 00:00:00 ET · period of report 2023-06-07 · accession 0001062993-23-013263 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-09 | 2023-06-07 | TECH | Kummeth Charles R. | CEO, Dir | S - Sale | $83.00 | -322 | 1.11M | -0.0% | -$26.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-07 | S | D | 322 | $83.00 | 1,112,817 | D | — | — | (F1) Includes (i) 11,448 shares of restricted stock for which the risk of forfeiture will lapse on August 5, 2023; and (ii) 14,248 shares of restricted stock for which the risk of forfeiture will lapse as to 7,128 shares on each of August 6, 2023 and August 6, 2024. |